Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiange Lu

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Biorxiv : the Preprint Server for Biology|March 23, 2026
No evidence for sleep-dependent memory generalization in a large online sampleTiange Lu, Zhuangning Ji, Alexa Tompary, et al.
Journal of Hematology & Oncology|March 2, 2025
CAR-NK cell therapy: latest updates from the 2024 ASH annual meetingRan Kong, Bingyu Liu, Hua Wang, et al.
Biomarker Research|April 21, 2021
Novel insights into the m<sup>6</sup>A-RNA methyltransferase METTL3 in cancerYiqing Cai, Rui Feng, Tiange Lu, et al.
Clinical and Translational Medicine|July 3, 2024
N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9Mengfei Ding, Zhuoya Yu, Tiange Lu, et al.
BMC Cancer|February 25, 2025
Autoimmune disease and risk of lymphoma: analysis from real-world data and Mendelian randomization studyLinquan Zhan, Siyuan Chen, Yingyue Liu, et al.
Journal of Advanced Research|October 21, 2023
Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolismXiaomin Chen, Tiange Lu, Mengfei Ding, et al.
Cell Death Discovery|February 1, 2023
PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrationsShunfeng Hu, Tiange Lu, Juanjuan Shang, et al.
Frontiers in Immunology|July 31, 2025
Response gene to complement 32 promotes tumorigenesis by mediating DNA damage repair and inhibits CD8+ T cells infiltration in diffuse large B-cell lymphomaXiyuan Zhang, Tiange Lu, Chunlei Shi, et al.
BMC Cancer|October 3, 2023
Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphomaZhuoya Yu, Mengfei Ding, Yiqing Cai, et al.
Cell Death Discovery|June 12, 2023
α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosisYiqing Cai, Liemei Lv, Tiange Lu, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|March 23, 2026
No evidence for sleep-dependent memory generalization in a large online sampleTiange Lu, Zhuangning Ji, Alexa Tompary, et al.
Journal of Hematology & Oncology|March 2, 2025
CAR-NK cell therapy: latest updates from the 2024 ASH annual meetingRan Kong, Bingyu Liu, Hua Wang, et al.
Biomarker Research|April 21, 2021
Novel insights into the m<sup>6</sup>A-RNA methyltransferase METTL3 in cancerYiqing Cai, Rui Feng, Tiange Lu, et al.
Clinical and Translational Medicine|July 3, 2024
N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9Mengfei Ding, Zhuoya Yu, Tiange Lu, et al.
BMC Cancer|February 25, 2025
Autoimmune disease and risk of lymphoma: analysis from real-world data and Mendelian randomization studyLinquan Zhan, Siyuan Chen, Yingyue Liu, et al.
Journal of Advanced Research|October 21, 2023
Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolismXiaomin Chen, Tiange Lu, Mengfei Ding, et al.
Cell Death Discovery|February 1, 2023
PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrationsShunfeng Hu, Tiange Lu, Juanjuan Shang, et al.
Frontiers in Immunology|July 31, 2025
Response gene to complement 32 promotes tumorigenesis by mediating DNA damage repair and inhibits CD8+ T cells infiltration in diffuse large B-cell lymphomaXiyuan Zhang, Tiange Lu, Chunlei Shi, et al.
BMC Cancer|October 3, 2023
Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphomaZhuoya Yu, Mengfei Ding, Yiqing Cai, et al.
Cell Death Discovery|June 12, 2023
α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosisYiqing Cai, Liemei Lv, Tiange Lu, et al.
Pageof 3